
Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB
HealthTree Podcast for Multiple Myeloma
00:00
Advancements in CAR-T Therapies for Multiple Myeloma
The chapter explores ongoing clinical trials for CAR-T therapies in earlier lines of therapy for multiple myeloma, showcasing positive results with over 50% reduction in progression risk. It compares CAR-T and Biaspecific antibodies, discussing mechanisms, sequencing strategies, and potential approval timelines. The importance of myeloma specialists in guiding treatment decisions, development of CAR-T with multiple targets, and the progress towards allogeneic CAR-T therapies are also discussed.
Transcript
Play full episode